Enterprise Value
237.1B
Cash
19.97B
Avg Qtr Burn
N/A
Short % of Float
0.81%
Insider Ownership
0.04%
Institutional Own.
70.67%
Qtr Updated
04/2/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Zavzpret (Zavegepant) Details Migraines | Approved Update | |
Approved Quarterly sales | ||
PREVNAR 20 (20-valent pneumococcal conjugate vaccine) (20vPnC) Details Invasive pneumococcal disease | Approved Quarterly sales | |
Oxbryta (Voxelotor) Details SCD (Sickle Cell Disease) | Approved Quarterly sales | |
Bivalent Respiratory Syncytial Virus (RSV) Vaccine /RSVpreF (Older adults) Details Respiratory syncytial virus, Respiratory virus | Approved Quarterly sales | |
Paxlovid Details COVID-19 | Approved Quarterly sales | |
TALA + enzalutamide Details Cancer, Prostate cancer, Castration-resistant prostate cancer | PDUFA Approval decision | |
BRAFTOVI + MEKTOVI Details Cancer, Non-small cell lung carcinoma | PDUFA Approval decision | |
Elranatamab Details Cancer, Multiple myeloma | PDUFA Approval decision | |
ABRYSVO (Respiratory Syncytial Virus Maternal Vaccine Candidate /RSVpreF/PF-06928316) Details Respiratory syncytial virus, Respiratory virus | PDUFA Approval decision | |
BLA Acceptance for review | ||
Aztreonam-Avibactam (ATM-AVI) Details Pneumonia, Bacterial infection, Intra-abdominal infections | NDA Submission | |
Inclacumab (P-selectin inhibitor) Details SCD (Sickle Cell Disease) | Phase 3 Data readout | |
Marstacimab Details Hemophilia | Phase 3 Data readout | |
Fidanacogene elaparvovec Details Hemophilia | Phase 3 Update | |
Troriluzole Details Obsessive compulsive disorder | Phase 2/3 Data readout | |
Troriluzole Details Alzheimer's disease | Failed Discontinued | |
Failed Discontinued | ||
Troriluzole Details Spinocerebellar Ataxia | Failed Discontinued | |
Verdiperstat Details Amyotrophic lateral sclerosis | Failed Discontinued | |
Verdiperstat Details Multiple System Atrophy | Failed Discontinued |